HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 115 filers reported holding HARROW HEALTH INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515 | +104.4% | 35,864 | +170.8% | 0.00% | – |
| Q2 2023 | $252 | -62.6% | 13,244 | -58.3% | 0.00% | – |
| Q1 2023 | $673 | +175.8% | 31,774 | +91.7% | 0.00% | – |
| Q4 2022 | $244 | -99.4% | 16,573 | +365.5% | 0.00% | – |
| Q3 2022 | $43,000 | +138.9% | 3,560 | +44.3% | 0.00% | – |
| Q2 2022 | $18,000 | +5.9% | 2,467 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -59.5% | 2,467 | -50.0% | 0.00% | – |
| Q4 2021 | $42,000 | -14.3% | 4,934 | -8.8% | 0.00% | – |
| Q3 2021 | $49,000 | +113.0% | 5,412 | +119.8% | 0.00% | – |
| Q2 2021 | $23,000 | -92.6% | 2,462 | -95.6% | 0.00% | – |
| Q3 2020 | $310,000 | +21.1% | 55,495 | +12.9% | 0.00% | – |
| Q2 2020 | $256,000 | +25500.0% | 49,136 | +12898.9% | 0.00% | – |
| Q1 2020 | $1,000 | -99.7% | 378 | -99.3% | 0.00% | – |
| Q3 2019 | $309,000 | – | 55,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |